• Cy5 Hydrazide (Non-Sulfonated): New Frontiers in Carbonyl La

  2026-05-09

  Explore the advanced uses of Cy5 hydrazide as a carbonyl-reactive fluorescent dye for precise biomolecule labeling. This article delivers unparalleled insight into assay optimization, protocol considerations, and translational impact—bridging nanotechnology and protein analytics.

• D-N-Acetylgalactosamine: Technical Guidance for Brain Glycop

  2026-05-08

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite suited for researchers analyzing glycoprotein structures and glycosylation pathways in brain tissues. It should not be used in protocols requiring ethanol solubility or long-term storage of solutions. Proper workflow setup and handling are essential to maintain experimental consistency.

• WM-8014: Precision KAT6A Inhibitor for Epigenetic Assays

  2026-05-08

  WM-8014 delivers unmatched selectivity for KAT6A/B, enabling robust oncogene-induced senescence and cell cycle arrest studies without confounding cytotoxicity. This article translates the latest CRISPR screen findings into actionable workflows and troubleshooting insights for advanced cancer biology research.

• MLN4924: Transforming NEDD8-Activating Enzyme Inhibition in

  2026-05-07

  MLN4924 is redefining approaches to cancer biology by selectively inhibiting the NEDD8-activating enzyme, enabling robust modulation of the neddylation pathway and cullin-RING ligase ubiquitination. Discover optimized workflows, actionable troubleshooting, and the translational impact of this selective NAE inhibitor—backed by both leading research and APExBIO’s trusted supply.

• Rottlerin: Selective PKC Inhibitor for Cell Proliferation St

  2026-05-07

  Rottlerin is a selective PKC inhibitor with high specificity for PKCδ, enabling precise modulation of cell proliferation and apoptosis in vitro and in vivo. Its defined IC50 profile and apoptosis induction make it a robust tool for cancer and cell signaling research (source: https://www.apexbt.com/rottlerin.html).

• Dimethyloxalylglycine (DMOG): Workflow Guidance for Hypoxia

  2026-05-06

  Dimethyloxalylglycine (DMOG) provides a practical solution for researchers needing to stabilize hypoxia-inducible factors and model hypoxia signaling pathways in vitro or in vivo, especially when environmental hypoxia is impractical. It should be used strictly for preclinical research applications, not for diagnostic or clinical purposes, and demands careful adherence to solubility and storage guidelines for reproducible results.

• H 89 2HCl Accelerates Precision in cAMP/PKA Pathway Research

  2026-05-06

  Leverage H 89 2HCl for robust, reproducible inhibition of cAMP/PKA signaling in cellular and biochemical assays. Explore workflow refinements, troubleshooting strategies, and direct translation of cutting-edge bone biology findings for advanced kinase research.

• RESTRICT-seq Reveals Epigenetic Dependencies in SCC Resistan

  2026-05-05

  The reference study presents RESTRICT-seq, a time-gated CRISPR screening approach that uncovers novel epigenetic regulators critical for squamous cell carcinoma (SCC) resistance. These findings highlight the importance of temporally-resolved gene perturbation in identifying actionable epigenetic drug targets, including KAT6A, for cancer biology research.

• Hemagglutinin mRNA Vaccine Protects Dairy Cows Against H5N1

  2026-05-05

  This study demonstrates the robust efficacy of a hemagglutinin-based mRNA–lipid nanoparticle vaccine in protecting lactating dairy cows against the highly pathogenic H5N1 influenza virus. The findings support mRNA vaccine strategies for zoonotic influenza containment and inform workflow choices in mRNA synthesis and vaccine development.

• DDX23 Restricts SVA via Caspase-Dependent Apoptosis Pathways

  2026-05-04

  This study uncovers how the host restriction factor DDX23 inhibits Senecavirus A (SVA) replication through selective degradation of viral proteins via the caspase-2/-6 and caspase-2/-3 apoptotic pathways. The identification of key amino acid residues governing this interaction provides new molecular targets for antiviral strategy development in swine disease research.

• EGCG Nanoparticles Enhance FLASH-RT Antitumor Efficacy via D

  2026-05-04

  Xu et al. demonstrate that functionalized self-assembled EGCG nanoparticles (BENPs) significantly potentiate DNA damage and immune activation during FLASH radiotherapy (FLASH-RT), resulting in superior tumor control compared to conventional approaches. This study addresses a major limitation of FLASH-RT—its insufficient intrinsic tumoricidal effect—by leveraging a radiosensitizer to augment both direct cytotoxic and immunomodulatory pathways.

• EPZ5676 (SKU A4166): Precision DOT1L Inhibition for Leukemia

  2026-05-03

  This article delivers a scenario-driven, evidence-based exploration of EPZ5676 (SKU A4166) for researchers tackling cell viability and cytotoxicity assays in MLL-rearranged leukemia models. By addressing real-world lab challenges, it demonstrates how EPZ5676’s selectivity, nanomolar potency, and robust compatibility streamline experimental workflows and improve reproducibility in epigenetic research.

• MDM1 Overexpression Boosts p53-Driven Apoptosis in CRC Chemo

  2026-05-02

  This study demonstrates that MDM1 overexpression enhances p53 expression and apoptosis, increasing colorectal cancer (CRC) cells' sensitivity to chemoradiotherapy. The findings identify MDM1 as a potential predictive biomarker and mechanistic modulator of therapeutic response in CRC.

• Leupeptin Hemisulfate Salt: Mechanistic Precision for Transl

  2026-05-01

  Explore how Leupeptin hemisulfate salt empowers translational researchers to precisely regulate protease activity, dissect protein degradation, and interrogate the metabolic-epigenetic interface. Mechanistic insights, evidence-backed guidance, and protocol parameters are presented to advance both experimental rigor and strategic innovation.

• RESTRICT-seq Unveils KAT6A Epigenetic Dependency in SCC Resi

  2026-05-01

  The referenced study introduces RESTRICT-seq, a time-gated CRISPR screening platform, to map temporal epigenetic dependencies in squamous cell carcinoma (SCC) resistance. This approach uncovers a critical role for KAT6A, highlighting new avenues for selective histone acetyltransferase inhibition in cancer biology research.

16175 records 1/1079 page Next 12345 下5页 Last page